Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000044

Options or other derivatives

  • Sr. VP & Chief Medical Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adda Nathalie · Sr. VP & Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-11-16 Grant or award : show line 1 in the form Stock Option (right to buy) +20,000 $81.20 2028-11-16 20,000 20,000 D
Loading xslF345X03/edgar.xml…